Dual targeting of the type 1 insulin-like growth factor receptor and its ligands as an effective antiangiogenic strategy

Clinical Cancer Research (2013) - Comments
pubmed: 23549869 doi: 10.1158/1078-0432.ccr-12-2008 issn: 1078-0432 issn: 1557-3265

Hemant K. Bid, Cheryl A. London, Jin Gao, Haihong Zhong, Robert E. Hollingsworth, Soledad Fernandez, Xiaokui Mo, Peter J. Houghton